TIDMAPH

RNS Number : 2782Z

Alliance Pharma PLC

25 May 2016

 
 For immediate release   25 May 2016

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Result of AGM

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, announces that all resolutions put to shareholders at today's Annual General Meeting were duly passed.

For further information:

 
 Alliance Pharma plc                                       + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
  Andrew Franklin, Chief Financial 
  Officer 
 Sarah Robinson, Company Secretary 
 www.alliancepharma.co.uk 
  Buchanan                                                + 44 (0) 20 7466 5000 
 Mark Court / Sophie Cowles / Jane 
  Glover 
 
 Numis Securities Limited                                 + 44 (0) 20 7260 1000 
 Nominated Adviser: Michael Meade / Freddie 
  Barnfield 
 Corporate Broking: James Black / 
  Toby Adcock

Notes to editors:

About Alliance Pharma

Alliance, founded in 1998, is an international specialty pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGAKPDDKBKDDPB

(END) Dow Jones Newswires

May 25, 2016 06:15 ET (10:15 GMT)

Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alliance Pharma Charts.
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alliance Pharma Charts.